These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9676895)

  • 1. Influence of interleukin-1beta on exploratory behaviors, plasma ACTH, corticosterone, and central biogenic amines in mice.
    Lacosta S; Merali Z; Anisman H
    Psychopharmacology (Berl); 1998 Jun; 137(4):351-61. PubMed ID: 9676895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral and neurochemical consequences of lipopolysaccharide in mice: anxiogenic-like effects.
    Lacosta S; Merali Z; Anisman H
    Brain Res; 1999 Feb; 818(2):291-303. PubMed ID: 10082815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central monoamine activity following acute and repeated systemic interleukin-2 administration.
    Lacosta S; Merali Z; Anisman H
    Neuroimmunomodulation; 2000; 8(2):83-90. PubMed ID: 10965233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-alpha: peripheral and central mechanisms.
    Hayley S; Wall P; Anisman H
    Eur J Neurosci; 2002 Mar; 15(6):1061-76. PubMed ID: 11918665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.
    Zalcman S; Green-Johnson JM; Murray L; Nance DM; Dyck D; Anisman H; Greenberg AH
    Brain Res; 1994 Apr; 643(1-2):40-9. PubMed ID: 7518332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations.
    Hayley S; Brebner K; Lacosta S; Merali Z; Anisman H
    J Neurosci; 1999 Jul; 19(13):5654-65. PubMed ID: 10377371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of subdiaphragmatic vagotomy on the noradrenergic and HPA axis activation induced by intraperitoneal interleukin-1 administration in rats.
    Wieczorek M; Dunn AJ
    Brain Res; 2006 Jul; 1101(1):73-84. PubMed ID: 16784727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice.
    Swiergiel AH; Dunn AJ
    Behav Brain Res; 2006 Jul; 171(1):94-108. PubMed ID: 16677721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of continuous infusion of interleukin-1beta on depression-related processes in mice: corticosterone, circulating cytokines, brain monoamines, and cytokine mRNA expression.
    Anisman H; Gibb J; Hayley S
    Psychopharmacology (Berl); 2008 Aug; 199(2):231-44. PubMed ID: 18491079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations.
    Brebner K; Hayley S; Zacharko R; Merali Z; Anisman H
    Neuropsychopharmacology; 2000 Jun; 22(6):566-80. PubMed ID: 10788757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological and behavioral responses to interleukin-1beta and LPS in vagotomized mice.
    Wieczorek M; Swiergiel AH; Pournajafi-Nazarloo H; Dunn AJ
    Physiol Behav; 2005 Jul; 85(4):500-11. PubMed ID: 15996692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the IL-1 receptor antagonist on the IL-1- and endotoxin-induced activation of the HPA axis and cerebral biogenic amines in mice.
    Dunn AJ
    Neuroimmunomodulation; 2000; 7(1):36-45. PubMed ID: 10601817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 and -6 induce behavioral-activating effects in mice.
    Zalcman S; Murray L; Dyck DG; Greenberg AH; Nance DM
    Brain Res; 1998 Nov; 811(1-2):111-21. PubMed ID: 9804916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships among the behavioral, noradrenergic, and pituitary-adrenal responses to interleukin-1 and the effects of indomethacin.
    Wieczorek M; Dunn AJ
    Brain Behav Immun; 2006 Sep; 20(5):477-87. PubMed ID: 16330180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Interleukin-1beta stimulates the simultaneous release of norepinephrine in the paraventricular nucleus and the median eminence.
    MohanKumar SM; MohanKumar PS
    Brain Res Bull; 2005 May; 65(5):451-6. PubMed ID: 15833600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety responses, plasma corticosterone and central monoamine variations elicited by stressors in reactive and nonreactive mice and their reciprocal F1 hybrids.
    Roy V; Merali Z; Poulter MO; Anisman H
    Behav Brain Res; 2007 Dec; 185(1):49-58. PubMed ID: 17692933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat.
    Connor TJ; Song C; Leonard BE; Merali Z; Anisman H
    Neuroscience; 1998 Jun; 84(3):923-33. PubMed ID: 9579794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide mediates the interleukin-1beta- and nicotine-induced hypothalamic-pituitary-adrenocortical response during social stress.
    Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 2005 Sep; 56(3):491-503. PubMed ID: 16204770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone.
    Dunn AJ
    Life Sci; 1988; 43(5):429-35. PubMed ID: 3260987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of interleukin-6 in the activation of the hypothalamo-pituitary-adrenocortical axis and brain indoleamines by endotoxin and interleukin-1 beta.
    Wang J; Dunn AJ
    Brain Res; 1999 Jan; 815(2):337-48. PubMed ID: 9878816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.